出血性中风 Initiative


This American Heart Association® initiative, sponsored by AstraZeneca, addresses the need for improved identification and treatment of hemorrhagic stroke patients.
The 出血性中风 Initiative is evaluating new efforts to enhance the care of hemorrhagic stroke patients in hospitals and stroke centers across America.
中风是不行的. 5 cause of death in the United States and a leading cause of disability. Hemorrhagic strokes make up roughly 10 percent of the nearly 800,000 strokes that occur annually, and they have a higher mortality rate than other types of stroke. Hemorrhagic stroke patients who are treated with novel oral anticoagulants, 或NOACs, have an in-hospital mortality rate of 26.5%.
Recognizing Early Adopters
查看早期采用者
Built on the foundation of Get With The Guidelines®
See below for the 2022 Guideline Update regarding Intracerebral Hemorrhage. For professional education regarding this guideline, we've assembled a supporting presentation for internal hospital use.

资源,在线研讨会 & 播客
Stay up-to-date with the American Heart Association's 出血性中风 Initiative. We will be posting webinars, podcasts, pathways & protocols, and other resources as they become available over the coming months. We also invite you to join our mailing list below to get even more information.
线上电子游戏飞禽走兽
Looking for more information or details? Reach out with questions.